SQZ Biotech has a promising new way of transforming cell behavior. This technology from MIT’s storied Langer Lab is backed by a $500 Million collaboration with Roche, the biggest maker of cancer drugs, and $24 million in VC money.

Sal Daher, CFA, together with other angels, is an investor in SQZ Biotech. To learn more about investing alongside Sal and his colleagues in this type of startup please enter your email address:

Investments in Startups are Inherently Risky. Such investments should only be undertaken by financially sophisticated persons who are accredited investors as defined under US securities laws and who are capable of bearing the risks involved. Do seek independent investment advice in making your decision to invest. We do not provide investment advice.

 

LISTEN TO SAL’S INTERVIEW OF ARMON SHAREI, CEO OF SQZ BIOTECH HERE


CURRENT PODCAST EPISODE

New Podcast Episodes Released Every Other Wednesday. 

 

Few are as well positioned to see the huge opportunities that exist for small and medium businesses in digital marketing as the founder of Constant Contact. In his new company, Brevi, Randy Parker is using software to allow mom & pop businesses to access those opportunities in ways that pay.

I had loads of fun talking to this most clever and affable guest; and I learned a lot.


FEATURED EPISODES


SUBSCRIBE

New episodes released every Wednesday. Subscribe to our podcast on iTunes to make certain you never miss an episode: